<?xml version="1.0" encoding="UTF-8"?>

<?xml-stylesheet type="text/xsl" href="/static/oaitohtml.xsl"?>

<!--
<?xml-stylesheet type="text/xsl" href="/oaitohtml.xsl"?>
-->

<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <responseDate>2026-10-12T13:20:50Z</responseDate>
    <request verb="GetRecord" metadataPrefix="oai_dc" identifier="10.57760/sciencedb.27202" >https://www.scidb.cn/oai</request>
<GetRecord>
    <record>
    <header >
    <identifier>10.57760/sciencedb.27202</identifier>
    <datestamp>2025-07-04T16:34:27Z</datestamp>
</header>
    <metadata>
        
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:date>2025-07-04</dc:date>
  <dc:title>Segmented filamentous bacteria confer protection against norovirus infection through enhanced viral clearance, immune modulation, and intestinal barrier function</dc:title>
  <dc:identifier>doi:10.57760/sciencedb.27202</dc:identifier>
  <dc:language>en</dc:language>
  <dc:description>we demonstrate that SFB profoundly accelerates viral clearance. SFB-colonized mice exhibited significantly reduced fecal viral loads by day 5 post-infection (dpi) compared to GF and control bacteria mice (p &amp;lt; 0.001), reaching near-baseline levels by day 10. This enhanced viral control correlated with markedly attenuated morbidity; SFB mice experienced minimal weight loss and rapid recovery, while GF and control mice suffered severe weight loss and delayed recovery (p &amp;lt; 0.001). At peak infection (3 dpi), SFB colonization significantly suppressed viral replication in feces and tissues and attenuated intestinal pathology. SFB also preserved barrier integrity, evidenced by reduced serum FITC-dextran. Mechanistically, SFB induced a distinctive antiviral cytokine profile, characterized by elevated IFN-&amp;lambda; and IL-22, while tempering IFN-&amp;gamma; increases. Protection was dose-dependent, with pre-infection SFB abundance strongly inversely correlating with day 3 viral load and pathology. Integrated multi-parameter and principal component analyses revealed a unique SFB-driven protective state, featuring accelerated clearance, reduced pathology/inflammation, barrier preservation, and elevated protective cytokines, establishing a pre-primed mucosal environment.</dc:description>
  <dc:subject>Segmented filamentous bacteria (SFB); Norovirus; Protective Mechanism; Immunomodulation; Intestinal Barrier Integrity</dc:subject>
  <dc:creator>NIGNBO LIAO</dc:creator>
  <dc:rights>PUBLIC</dc:rights>
  <dc:rights>https://opendatacommons.org/licenses/by/1-0/</dc:rights>
  <dc:type>dataset</dc:type>
  <dc:publisher>Science Data Bank</dc:publisher>
</oai_dc:dc>

    </metadata>
</record>
</GetRecord>
</OAI-PMH>